TEDC2 and cancer: We also found genes that, to our knowledge, have no previously reported driver NCVs with TFA-BT NCVs in at least 5% of tumors within certain cancer types, such as RPL13A (bladder and skin cancer), TEDC2 (skin cancer), and PES1 (skin cancer) (Supplementary Fig. 1b).